BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3012375)

  • 21. The action of AD6 on experimental arrhythmias and on action potentials of cardiac fibers.
    Bertolino M; Prosdocimi M; Aporti F; Finesso M; Gorio A
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):66-78. PubMed ID: 3753098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
    Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
    Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet action of 3',4'-diisovalerylkhellactone diester purified from Peucedanum japonicum Thunb.
    Hsiao G; Ko FN; Jong TT; Teng CM
    Biol Pharm Bull; 1998 Jul; 21(7):688-92. PubMed ID: 9703250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A formula for correcting for the in vitro release of platelet beta-thromboglobulin.
    van Wyk V; Heyns AD; de Wet JI; Kotzé HF; Lötter MG
    Thromb Res; 1987 Jun; 46(5):659-68. PubMed ID: 2957816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.
    Ribaldi E; Mezzasoma AM; Francescangeli E; Prosdocimi M; Nenci GG; Goracci G; Gresele P
    Br J Pharmacol; 1996 Jul; 118(6):1351-8. PubMed ID: 8832056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet activation during steady state sickle cell disease.
    Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
    J Med; 1983; 14(1):17-36. PubMed ID: 6224876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated?
    Benigni A; Livio M; Dodesini P; Schieppati A; Panigada M; Mecca G; de Gaetano G; Remuzzi G
    Am J Nephrol; 1985; 5(4):243-7. PubMed ID: 2996352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes.
    De La Cruz JP; Páez MV; Carmona JA; De La Cuesta FS
    Br J Pharmacol; 1999 Dec; 128(7):1538-44. PubMed ID: 10602334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alkaline phosphatase prevents platelet stimulation by thromboxane-mimetics.
    Hatmi M; Haye B; Gavaret JM; Vargaftig BB; Jacquemin C
    Br J Pharmacol; 1991 Oct; 104(2):554-8. PubMed ID: 1665743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
    Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
    Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation.
    Donato JL; Marcondes S; Antunes E; Nogueira MD; Nader HB; Dietrich CP; Rendu F; de Nucci G
    Br J Pharmacol; 1996 Dec; 119(7):1447-53. PubMed ID: 8968554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of rhynchophylline on platelet aggregation and thrombosis.
    Chen CX; Jin RM; Li YK; Zhong J; Yue L; Chen SC; Zhou JY
    Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):126-30. PubMed ID: 1317985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet effect of hsien-ho-t'sao (Agrimonia pilosa).
    Wang JP; Hsu MF; Teng CM
    Am J Chin Med; 1985; 13(1-4):109-18. PubMed ID: 3927704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
    Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
    Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloricromene inhibits G-protein-mediated activation of phospholipase A2 in human platelets.
    Stasi M; Gresele P; Prosdocimi M; Porcellati S; Quero E; Pieretti G; Nenci GG; Goracci G
    J Lipid Mediat; 1993 Jul; 7(3):253-67. PubMed ID: 8219005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid.
    Vissinger H; Husted SE; Kristensen SD; Nielsen HK
    Angiology; 1993 Aug; 44(8):633-8. PubMed ID: 8342880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of cyclooxygenase activity and increase in platelet cyclic AMP by girinimbine, isolated from Murraya euchrestifolia.
    Ko FN; Lee YS; Wu TS; Teng CM
    Biochem Pharmacol; 1994 Jul; 48(2):353-60. PubMed ID: 8053931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal and maternal platelets: activation at time of birth.
    Suarez CR; Gonzalez J; Menendez C; Fareed J; Fresco R; Walenga J
    Am J Hematol; 1988 Sep; 29(1):18-21. PubMed ID: 2972197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.